Enhancing treatments for myeloid leukemia with Down syndrome

Who could benefit from this research

What this research studies

Children with ML-DS respond unusually well to AraC-based treatment, but the exact biology behind this is not fully understood. The study focuses on the bone marrow environment, especially endothelial cells, and how their interactions with ML-DS cells influence chemotherapy sensitivity and relapse. The researchers will examine differences in endothelial cell behavior from various tissues and disease states to see how these interactions could be driving durable responses or resistance. By uncovering these mechanisms, the project seeks to identify targets to further reduce relapse and improve outcomes for ML-DS patients. The work leverages lab studies that model human disease with patient-derived samples and cell systems to translate findings toward better therapies.

Why it matters

Where this research is happening

• Wayne State University
  Detroit, United States Active

Researchers

• Principal investigator: Taub, Jeffrey Warren — Wayne State University
• Study coordinator: Taub, Jeffrey Warren

Related research

Other NIH-funded projects on the same topics.

• Preventing fatal infections in children with Down syndrome during ALL treatment

  Aimed at reducing deadly infections in children with Down syndrome undergoing chemotherapy for acute lymphoblastic leukemia by finding biomarkers to tailor treatment and supportive care.

  NIH research Columbia University Health Sciences · New York, United States · NIH-11398896

• Chronic health problems in children with Down syndrome who survived leukemia

  This project looks at long-term health issues in kids with Down syndrome who have survived leukemia to understand what problems they may face later on.

  NIH research Baylor College of Medicine · Houston, United States · NIH-11389546

• Better treatments for myeloid leukemia in children with Down syndrome

  This project looks at how bone marrow blood-vessel cells influence why chemotherapy works so well for children with Down syndrome who develop myeloid leukemia.

  NIH research Wayne State University · Detroit, United States · NIH-11145814

• Long-term health after leukemia in children with Down syndrome

  This project looks at ongoing medical and thinking problems in children with Down syndrome who had acute leukemia compared with children with Down syndrome who never had cancer.

  NIH research Baylor College of Medicine · Houston, United States · NIH-11125753

• Preventing deadly infections in children with Down syndrome during leukemia treatment

  This project looks for blood markers that can identify children with Down syndrome and acute lymphoblastic leukemia who are at high risk for life-threatening infections so doctors can offer extra protection early.

  NIH research Columbia University Health Sciences · New York, United States · NIH-11093995

• Investigating the link between Down syndrome and acute lymphoblastic leukemia in children

  This study is looking into why kids with Down syndrome are more likely to get a type of blood cancer called acute lymphoblastic leukemia, and it hopes to find out how their genes play a role in this so that we can help keep them healthier.

  NIH research Baylor College of Medicine · Houston, United States · NIH-10908747

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.